drugset / Trial / NCT07457203
Study on the Drug Interaction Between Buagafuran and Voriconazole
NaSingle-groupOpen-labelOther
Summary
This study is a non-randomized, open label trial aimed at evaluating the drug interaction between Buagafuran capsules and voriconazole tablets in Chinese adult healthy participants.The research period is 7 days in total.
Timeline
- Start
- 2026-04
- Primary completion
- 2026-05
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buagafuran | Unknown | 30 mg | Oral |
| Subject | Voriconazole | Small molecule | 200 mg | Oral |
Indications
No indication recorded.